SUBSTRATA MAIN PAGE|
TAXONOMY: Bacteria -> Proteobacteria -> Gammaproteobacteria -> Enterobacteriales -> Enterobacteriaceae -> Citrobacter -> Citrobacter freundii
Citrobacter freundii is a species of facultative, anaerobic Gram-negative bacilli of the Enterobacteriaceae family. The bacteria are long bacterial rods with a typical length of 1–5 μm. Most C. freundii cells generally have several flagella used for locomotion, but some do not and are non-motile. C. freundii is a soil organism, but can also be found in water, sewage, food and in the intestinal tracts of animals and humans. The Citrobacter genus was discovered in 1932 by Werkman and Gillen. Cultures of C. freundii were isolated and identified in the same year from soil extracts.As an opportunistic pathogen, C. freundii is responsible for a number of significant infections. It is known to be the cause of nosocomial infections of the respiratory tract, urinary tract, blood, and many other normally sterile sites in patients. C. freundii represents about 29% of all opportunistic infections. Though a pathogen to humans, this infectious microbe in humans plays an important role in the nitrogen cycle in the environment. C. freundii is responsible for reducing nitrate to nitrite in the environment. This conversion is an important and crucial stage in the nitrogen cycle. C. freundii has also been investigated for biodegradation of tannic acid used in tanneries. C. freundii has the ability to grow on glycerol, and use it as its sole source of carbon and energy. The organism contains a bacterial microcompartment which is capable of processing propanediol.
This genus contains microbial species that can reside in the human gastrointestinal tract. [PMC 4262072]
|COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Citrobacter freundii ranks 2 on this scale: Species that can cause diseases in humans or animals, which are
unlikely to spread in the human population and for which an adequate
prophylaxis or therapy exists|